Bg pattern

CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

cinfamucol carbocisteína 750 mg oral solution in sachets

Read this package leaflet carefully before starting to take this medicine, as it contains important information for you.

Follow the administration instructions of the medicine contained in this package leaflet or as indicated by your doctor or pharmacist.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.
  • You should consult a doctor if your condition worsens or does not improve after 5 days of treatment.

Contents of the Package Leaflet

  1. What cinfamucol carbocisteína is and what it is used for.
  2. What you need to know before taking cinfamucol carbocisteína.
  3. How to take cinfamucol carbocisteína.
  4. Possible side effects.
  5. Storage of cinfamucol carbocisteína.
  6. Contents of the pack and further information.

1. What cinfamucol carbocisteína is and what it is used for

Carbocisteína, the active ingredient of this medicine, belongs to the group of medicines called mucolytics, which act by decreasing the viscosity of mucus, making it more fluid and facilitating its elimination.

This medicine is indicated to facilitate the elimination of excess mucus and phlegm in colds and flu for adults and adolescents from 12 years of age.

You should consult your doctor if your condition worsens or does not improve after 5 days of treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking cinfamucol carbocisteína

Do not take cinfamucol carbocisteína

If you are allergic to carbocisteína and its derivatives, or to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to take cinfamucol carbocisteína.

  • If you have stomach ulcers, duodenal ulcers, or any thyroid disease.
  • If you have asthma or any severe respiratory disease, as it may increase respiratory tract obstruction.

During the first days of treatment, you may observe an increase in mucus and phlegm, which will decrease throughout the treatment.

Children

Do not administer this medicine to children under 12 years of age.

Other medicines and cinfamucol carbocisteína

Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine.

Do not take this medicine with medicines used to reduce non-productive cough (antitussives) or with medicines used to decrease bronchial secretions, as it may cause an accumulation of fluidified mucus.

Taking cinfamucol carbocisteína with food and drinks

Take this medicine preferably before meals. See section 3. How to take cinfamucol carbocisteína.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

This medicine is not recommended for pregnant or breastfeeding women.

Driving and using machines

The influence of cinfamucol carbocisteínaon the ability to drive and use machines is nil or insignificant.

cinfamucol carbocisteína contains orange yellow (E-110). This medicine may cause allergic reactions because it contains orange yellow (E-110). It may cause asthma, especially in patients allergic to acetylsalicylic acid.

cinfamucol carbocisteína contains methyl parahydroxybenzoate (E-219) and propyl parahydroxybenzoate (E-217). It may cause allergic reactions (possibly delayed) because it contains methyl parahydroxybenzoate (sodium salt) (E-219) and propyl parahydroxybenzoate (sodium salt) (E-217).

cinfamucol carbocisteína contains sodium. This medicine contains 136.65 mg of sodium (main component of table salt/cooking salt) per sachet. This is equivalent to 6.8% of the maximum daily sodium intake recommended for an adult.

cinfamucol carbocisteína contains maltitol. This medicine contains maltitol (E-965). If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

cinfamucol carbocisteína contains propylene glycol. This medicine contains 90 mg of propylene glycol per sachet.

3. How to take cinfamucol carbocisteína

Follow the administration instructions of the medicine contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

The recommended dose is:

Adults and adolescents from 12 years of age: 1 sachet every 8 hours. Do not take more than 3 sachets per day, divided into 3 doses. Once you observe improvement, you can reduce to 2 sachets in 24 hours, divided into 2 doses. The dose is up to 10 ml of oral solution (500 mg of carbocisteína) 3 times a day, which means a maximum daily dose of 30 ml of oral solution (1.5 g of carbocisteína).

How to take

This medicine is taken orally.

Open the sachet and pour the contents directly into the mouth. It is recommended to drink a glass of water after each dose and a large amount of liquid throughout the day.

If your condition worsens, or if symptoms persist after 5 daysof treatment, or if you experience: fever, skin rash, persistent headache, or sore throat, you should consult your doctor.

Use in children

Children under 12 years of age cannot take this medicine.

If you take more cinfamucol carbocisteína than you should

If you have taken more cinfamucol carbocisteína than you should, you may notice stomach pain, nausea, and diarrhea, itching, and skin rash.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take cinfamucol carbocisteína

Do not take a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

During the use of carbocisteína, the following side effects have been observed, whose frequency cannot be established with precision.

Rarely, nausea, stomach discomfort, or diarrhea may appear, which usually disappear when the dose is reduced.

Rarely, other reactions such as stomach or intestinal bleeding, headache, itching, skin rash, and angioedema (swelling of certain areas of the skin) have been observed.

In these cases, it is advisable to interrupt treatment and consult a doctor.

Reporting of side effects:

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of cinfamucol carbocisteína

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.

Do not store above 30°C.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and further information

Composition of cinfamucol carbocisteína

  • Each sachet contains 750 mg of carbocisteína as the active ingredient.
  • The other components (excipients) are: liquid maltitol (E-965), sodium hydroxide (E-524), sodium citrate (E-331), propylene glycol (E-1520), hydroxyethylcellulose, citric acid monohydrate, methyl parahydroxybenzoate (sodium salt) (E-219), sodium saccharin, orange flavor (flavoring preparations, flavoring substances, natural flavoring substances, corn maltodextrin, gum arabic (E-414), ascorbic acid (E-300), and butylated hydroxyanisole (BHA) (E-320)), propyl parahydroxybenzoate (sodium salt) (E-217), orange yellow (E-110), and purified water.

Appearance of the product and contents of the pack

cinfamucol carbocisteína is a clear oral solution with an orange flavor. Each pack contains 12 sachets.

Marketing authorization holder and manufacturer

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

Date of the last revision of this package leaflet:October 2021

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS

Discuss questions about CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS?
CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS?
The active ingredient in CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS is carbocisteine. This information helps identify medicines with the same composition but different brand names.
Who manufactures CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS?
CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS is manufactured by Laboratorios Cinfa S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CINFAMUCOL CARBOCISTEINE 750 MG ORAL SOLUTION IN SACHETS?
Other medicines with the same active substance (carbocisteine) include ACTITHIOL MUCOLITIC INFANTILE 20 mg/ml ORAL SOLUTION, CINFAMUCOL CARBOCISTEINE 50 mg/ml ORAL SOLUTION, FLUIDIN MUCOLITIC 50 mg/ml ORAL SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media